Join us on September 3rd, 15:00 CET for a live session for life sciences commercial, marketing, and medical leaders.
Reaching healthcare professionals in Europe means engaging thousands of physicians quickly, personally, and in full compliance with GDPR and e-privacy, whether you are launching a new medicine, moving into new markets, or building consent for a product already on the market. But most teams start with too few consented email addresses, a shrinking field force, and 26+ markets that each have their own rules and codes of conduct. Engagement stalls, and the opt-in data that does get collected often gets rejected by legal because it was never captured in a compliant way.
This session shows how three specialists (OptInsight, TSD, and Sciential) combine digital campaigns, personal phone outreach, and consent management into one service that reaches 90 to 95% of your target HCPs with a 45 to 65% opt-in ratio, fully GDPR and e-privacy-proof and ready to activate in your CRM and marketing automation.
In 45 minutes, we will cover how to:
- Build a compliant, consented HCP database, without buying data or standing up an in-house team.
- Combine digital and phone so every physician is warmed up before the first call, which is the difference between a 20% and a 65% opt-in.
- Capture GDPR-proof opt-ins your legal and privacy teams will actually approve, and sync them straight into your CRM.
- Go live in 4 to 6 weeks and reach 90 to 95% of your target audience across European markets.
We will walk through real campaign results and show how this approach changes the way biotech and pharma engage HCPs in Europe. Followed by live Q&A.
Who is this for?
Marketing, commercial, and medical teams at biotech and pharma companies building HCP engagement in Europe, whether for a new launch, a new indication or market, or an existing product where consent still needs to be collected.
Save your seat👇
